Thursday, August 25, 2016 1:50:44 PM
1) Exhaust every VNTH dollar on "research", drive that sucker into the
ground for the sake of Nanobeak intellectual capital;
2) Jettison us & the company, and leave Nanobeak
safe and sound, probably with its recently "cloned"
website of the VNTH website for next stage of profit,
with no financial commitment to VNTH or its shareholders? Or wait: the
next RS at a 1000:1 leaves you with NEXT TO nothing, them with all the
intellectual capital built from activities and licenses secured with
VNTH monies most likely (Nanobeak has the license, not VNTH, lmao).
3) Get ready for the big pharma buyout, now that we're gone and their
product is entirely controlled by the private "cabal";
4) Timeline: after the political season, clean house since what people
think doesn't matter at all again, and the shareholder punishment may
continue unabated. RS. Hands are tied. We had to sell and it was a
condition of the sale, too bad, etc. Lather rinse repeat. The vision
was laid out with the special share shuffle in 2015, possibly.
All imo, wait and watch as reality plays out and we test predictions.
SD
Boy that Nanobeak site for the private company looks great! lmao
Recent VNTH News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 09:30:06 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM